Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Exp Gerontol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    April 2019
  1. JENSEN CS, Bahl JM, Ostergaard LB, Hogh P, et al
    Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
    Exp Gerontol. 2019 Apr 10. pii: S0531-5565(18)30714.
    PubMed     Text format     Abstract available


    February 2019
  2. HAYASHI K, Hasegawa Y, Takemoto Y, Cao C, et al
    Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease.
    Exp Gerontol. 2019 Feb 17. pii: S0531-5565(18)30570.
    PubMed     Text format     Abstract available


    January 2019
  3. ZENG Q, Siu W, Li L, Jin Y, et al
    Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine.
    Exp Gerontol. 2019 Jan 30. pii: S0531-5565(18)30772.
    PubMed     Text format     Abstract available


  4. MURALEVA NA, Stefanova NA, Kolosova NG
    p38 MAPK-dependent alphaB-crystallin phosphorylation in Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2019 Jan 18. pii: S0531-5565(18)30613.
    PubMed     Text format     Abstract available


    December 2018
  5. ABRAHAM D, Feher J, Scuderi GL, Szabo D, et al
    Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome.
    Exp Gerontol. 2018 Dec 6. pii: S0531-5565(18)30638.
    PubMed     Text format     Abstract available


    November 2018
  6. BEAUCHET O, Launay CP, Sekhon H, Montembeault M, et al
    Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease: Results from a cross-sectional study.
    Exp Gerontol. 2018 Nov 14. pii: S0531-5565(18)30586.
    PubMed     Text format     Abstract available


  7. RUDNITSKAYA EA, Kozlova TA, Burnyasheva AO, Kolosova NG, et al
    Alterations of hippocampal neurogenesis during development of Alzheimer's disease-like pathology in OXYS rats.
    Exp Gerontol. 2018 Nov 8. pii: S0531-5565(18)30409.
    PubMed     Text format     Abstract available


    September 2018
  8. DRYGALSKI K, Fereniec E, Korycinski K, Chomentowski A, et al
    Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
    Exp Gerontol. 2018;113:36-47.
    PubMed     Text format    


    August 2018
  9. HUTTER-SCHMID B, Humpel C
    Primary mouse brain pericytes isolated from transgenic Alzheimer mice spontaneously differentiate into a CD11b(+) microglial-like cell type in vitro.
    Exp Gerontol. 2018 Aug 9. pii: S0531-5565(18)30435.
    PubMed     Text format     Abstract available


    July 2018
  10. TOROSYAN N, Sethanandha C, Grill JD, Dilley ML, et al
    Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Exp Gerontol. 2018;111:118-121.
    PubMed     Text format     Abstract available


    June 2018
  11. SHEKHAR S, Yadav Y, Singh AP, Pradhan R, et al
    Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.
    Exp Gerontol. 2018 Jun 27. pii: S0531-5565(18)30302.
    PubMed     Text format     Abstract available


  12. BUFFA R, Mereu E, Putzu P, Mereu RM, et al
    Corrigendum to "Lower lean mass and higher percent fat mass in patients with Alzheimer's disease" [Exp. Gerontol. 58 (2014) 30-33].
    Exp Gerontol. 2018 Jun 2. pii: S0531-5565(18)30330.
    PubMed     Text format    


    April 2018
  13. KUGA GK, Munoz VR, Gaspar RC, Nakandakari SCBR, et al
    Impaired insulin signaling and spatial learning in middle-aged rats: The role of PTP1B.
    Exp Gerontol. 2018;104:66-71.
    PubMed     Text format     Abstract available


    March 2018
  14. KUNUTSOR SK, Laukkanen JA, Burgess S
    Genetically elevated gamma-glutamyltransferase and Alzheimer's disease.
    Exp Gerontol. 2018 Mar 2. pii: S0531-5565(18)30042.
    PubMed     Text format     Abstract available


    January 2018
  15. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Text format     Abstract available


    December 2017
  16. LE PAGE A, Dupuis G, Frost EH, Larbi A, et al
    Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Exp Gerontol. 2017 Dec 21. pii: S0531-5565(17)30541.
    PubMed     Text format     Abstract available


    November 2017
  17. MEREU E, Succa V, Buffa R, Sanna C, et al
    Total body and arm bioimpedance in patients with Alzheimer's disease.
    Exp Gerontol. 2017 Nov 21. pii: S0531-5565(17)30668.
    PubMed     Text format     Abstract available


    October 2017
  18. YASHIN AI, Fang F, Kovtun M, Wu D, et al
    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
    Exp Gerontol. 2017 Oct 26. pii: S0531-5565(17)30424.
    PubMed     Text format     Abstract available


  19. MATHYS J, Gholamrezaee M, Henry H, von Gunten A, et al
    Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Exp Gerontol. 2017 Oct 17. pii: S0531-5565(17)30465.
    PubMed     Text format     Abstract available


  20. FARINA N, Jerneren F, Turner C, Hart K, et al
    Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Exp Gerontol. 2017 Oct 9. pii: S0531-5565(17)30374.
    PubMed     Text format     Abstract available


    August 2017
  21. SCARABINO D, Broggio E, Gambina G, Corbo RM, et al
    Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2017 Aug 18. pii: S0531-5565(17)30445.
    PubMed     Text format     Abstract available


    July 2017
  22. CROTEAU E, Castellano CA, Fortier M, Bocti C, et al
    A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Exp Gerontol. 2017 Jul 11. pii: S0531-5565(17)30228.
    PubMed     Text format     Abstract available


    May 2017
  23. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Text format     Abstract available


    March 2017
  24. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Text format     Abstract available


    February 2017
  25. HUANG M, Jiang X, Liang Y, Liu Q, et al
    Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Exp Gerontol. 2017;91:25-33.
    PubMed     Text format     Abstract available


  26. MACKLIN L, Griffith CM, Cai Y, Rose GM, et al
    Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Exp Gerontol. 2017;88:9-18.
    PubMed     Text format     Abstract available


    January 2017
  27. GARD PR, Fidalgo S, Lotter I, Richardson C, et al
    Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Exp Gerontol. 2017 Jan 6. pii: S0531-5565(17)30006.
    PubMed     Text format     Abstract available


    December 2016
  28. SCARABINO D, Broggio E, Gambina G, Pelliccia F, et al
    Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimer's disease.
    Exp Gerontol. 2016 Dec 27. pii: S0531-5565(16)30423.
    PubMed     Text format     Abstract available


  29. BARRON M, Gartlon J, Dawson LA, Atkinson PJ, et al
    A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.
    Exp Gerontol. 2016 Dec 12. pii: S0531-5565(16)30580.
    PubMed     Text format     Abstract available


  30. NAKAGAWA T, Hasegawa Y, Uekawa K, Kim-Mitsuyama S, et al
    Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Exp Gerontol. 2016 Dec 1. pii: S0531-5565(16)30318.
    PubMed     Text format     Abstract available


    November 2016
  31. TARANTINI S, Tran CH, Gordon GR, Ungvari Z, et al
    Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
    Exp Gerontol. 2016 Nov 11. pii: S0531-5565(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  32. ZHANG ZX, Zhao RP, Wang DS, Wang AN, et al
    Fuzhisan ameliorates Abeta production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Exp Gerontol. 2016;84:88-95.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: